Satellos Bioscience Inc. — Investor Relations & Filings

Satellos Bioscience Inc. is a clinical-stage drug development company focused on the discovery and advancement of small molecule therapeutics for degenerative muscle diseases. The company's research centers on restoring the body's innate capacity for skeletal muscle repair and regeneration, specifically targeting Duchenne muscular dystrophy (DMD) and other neuromuscular disorders. By leveraging proprietary insights into muscle stem cell polarity and asymmetric division, Satellos aims to correct the regenerative deficits that drive muscle wasting. Its therapeutic approach focuses on stimulating the production of new muscle fibers to improve functional outcomes for patients. The company utilizes a specialized discovery platform to identify compounds that modulate the signaling pathways responsible for muscle stem cell regulation and tissue maintenance.